^
CANCER:

Salivary Gland Cancer





Show legend
Group by Gene:
0
Androgen receptor inhibitor
bicalutamide
darolutamide
1
Tubulin polymerization promoter, DNA synthesis inhibitor
carboplatin + gemcitabine
2
Tubulin polymerization promoter, Bcl2 inhibitor
paclitaxel
carboplatin + paclitaxel
3
GnRH agonist
leuprolide acetate
trastuzumab
4
HER2 inhibitor
trastuzumab-pkrb
ACE1702
5
TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
larotrectinib
6
HER2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
fam-trastuzumab deruxtecan-nxki
7
PD1 inhibitor
pembrolizumab
PD1 inhibitor
8
HER2 inhibitor, HER2 dimerization inhibitor
trastuzumab + pertuzumab
9
RET inhibitor
pralsetinib
selpercatinib
10
CYP17A1 inhibitor
abiraterone acetate
11
MEK inhibitor, BRAF inhibitor
trametinib + dabrafenib
12
EGFR inhibitor
cetuximab
13
AKT inhibitor
capivasertib
14
CXCL12 inhibitor, Farnesyl transferase inhibitor
tipifarnib
15
Hedgehog cell-signalling pathway inhibitor
vismodegib
16
ALK inhibitor, Multi-tyrosine kinase inhibitor
crizotinib + pazopanib
17
MDM2 inhibitor
APG-115
18
FGFR inhibitor
ABSK091
19
Multi-tyrosine kinase inhibitor
vandetanib
20
ALK inhibitor
alectinib
21
Tubulin polymerization inhibitor, DNA synthesis inhibitor
cisplatin + vinorelbine tartrate
22
Topoisomerase II inhibitor, Alkylating agent, DNA synthesis inhibitor
cisplatin + doxorubicin hydrochloride + cyclophosphamide
23
TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
entrectinib
ado-trastuzumab emtansine
24
HER2-targeted antibody-drug conjugate, Microtubule inhibitor
disitamab vedotin
ARX788
25
Androgen receptor inhibitor, GnRH agonist
leuprolide acetate + bicalutamide
26
FGFR2 inhibitor, FGFR inhibitor, FGFR1 inhibitor, FGFR3 inhibitor, FGFR4 inhibitor
erdafitinib
27
HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
pyrotinib
No biomarker
AR positive
AR expression
HER-2 positive
HER-2 amplification
HER-2 expression
HER-2 L755S
HER-2 overexpression
HER-2 amplification + HER-2 mutation
RET fusion
PD-L1 expression
NTRK3 fusion
FGFR fusion
FGFR mutation
MET N375S
PLIN2 expression
BRAF V600E
HRAS mutation
NTRK2 fusion
PTEN expression
PTCH1 mutation
NTRK1 fusion
EGFR expression
AKT1 E17K
TP53 wild-type
AR positive + HER-2 amplification
BAG4-FGFR1 B2F6
PIK3CA H1047R
EML4-ALK fusion
ETV6-NTRK3 fusion